Profile
James Ferguson Hill served as Non-Executive Chairman at Genetix Group Ltd. from 2000 to 2010.
He was also Director & Senior VP-Corporate Affairs at SmithKline Beecham Ltd. from 1994 to 2001.
Currently, he is an Independent Director at Akari Therapeutics Plc, a position he has held since 2015 and will hold until 2023.
Former positions of James Hill
| Companies | Position | End |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Director/Board Member | 30/06/2023 |
Genetix Group Ltd.
Genetix Group Ltd. Medical SpecialtiesHealth Technology Provides solutions for imaging and intelligent image analysis in the life science and diagnostic markets | Chairman | 14/01/2010 |
SmithKline Beecham Ltd.
SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 01/01/2001 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Genetix Group Ltd.
Genetix Group Ltd. Medical SpecialtiesHealth Technology Provides solutions for imaging and intelligent image analysis in the life science and diagnostic markets | Health Technology |
SmithKline Beecham Ltd.
SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Akari Therapeutics Plc
Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- James Hill
















